{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T17:03:58Z","timestamp":1785171838521,"version":"3.55.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006407","name":"Henan Province Natural Science Foundation","doi-asserted-by":"publisher","award":["252300421271"],"award-info":[{"award-number":["252300421271"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2023M743233"],"award-info":[{"award-number":["2023M743233"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82020108030"],"award-info":[{"award-number":["82020108030"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U21A20416"],"award-info":[{"award-number":["U21A20416"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017700","name":"Henan Provincial Science and Technology Research Project","doi-asserted-by":"publisher","award":["252102311230"],"award-info":[{"award-number":["252102311230"]}],"id":[{"id":"10.13039\/501100017700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bmcl.2025.130399","type":"journal-article","created":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T22:10:19Z","timestamp":1757542219000},"page":"130399","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Design, synthesis and biological evaluation of novel histone deacetylase 6 inhibitors containing indole-based cap groups"],"prefix":"10.1016","volume":"129","author":[{"given":"Xinhui","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiqian","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junru","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengkai","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiqin","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanfan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liying","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2025.130399_bb0005","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","article-title":"Gastric cancer","volume":"396","author":"Smyth","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.bmcl.2025.130399_bb0010","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1021\/acs.jmedchem.2c01593","article-title":"Phenothiazine-based LSD1 inhibitor promotes T-cell killing response of gastric cancer cells","volume":"66","author":"Dai","year":"2023","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130399_bb0015","doi-asserted-by":"crossref","first-page":"e943","DOI":"10.1016\/S2468-2667(23)00211-6","article-title":"National and subnational trends in cancer burden in China, 2005-20: an analysis of national mortality surveillance data","volume":"8","author":"Qi","year":"2023","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.bmcl.2025.130399_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107823","article-title":"TAS-102: a resurrected novel Fluoropyrimidine with expanding role in the treatment of gastrointestinal malignancies","volume":"224","author":"Chakrabarti","year":"2021","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.bmcl.2025.130399_bb0025","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1053\/j.gastro.2023.12.022","article-title":"Global prevalence of helicobacter pylori infection and incidence of gastric Cancer between 1980 and 2022","volume":"166","author":"Chen","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bmcl.2025.130399_bb0030","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1200\/JCO.22.00221","article-title":"Phase II LEAP-004 study of Lenvatinib plus Pembrolizumab for melanoma with confirmed progression on a programmed cell death protein-1 or programmed death ligand 1 inhibitor given as monotherapy or in combination","volume":"41","author":"Arance","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bmcl.2025.130399_bb0035","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.trecan.2024.03.008","article-title":"Gastric cancer immunosuppressive microenvironment heterogeneity: implications for therapy development","volume":"10","author":"Yasuda","year":"2024","journal-title":"Trends Cancer"},{"key":"10.1016\/j.bmcl.2025.130399_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108417","article-title":"Detailed curriculum vitae of HER2-targeted therapy","volume":"245","author":"Zhang","year":"2023","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.bmcl.2025.130399_bb0045","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-022-01557-1","article-title":"LSD1 deletion decreases exosomal PD-L1 and restores T-cell response in gastric cancer","volume":"21","author":"Shen","year":"2022","journal-title":"Mol Cancer"},{"key":"10.1016\/j.bmcl.2025.130399_bb0050","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1021\/acs.jmedchem.1c01863","article-title":"Discovery of novel histone deacetylase 6 (HDAC6) inhibitors with enhanced antitumor immunity of anti-PD-L1 immunotherapy in melanoma","volume":"65","author":"Peng","year":"2022","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130399_bb0055","article-title":"Histone deacetylase 6 (HDAC6) in ciliopathies: emerging insights and therapeutic implications","author":"Wang","year":"2025","journal-title":"Adv Sci (Weinheim, Baden-Wurttemberg, Germany)"},{"key":"10.1016\/j.bmcl.2025.130399_bb0060","article-title":"Development of hydrazide-based HDAC6 selective inhibitors for treating NLRP3 inflammasome-related diseases","author":"Yue","year":"2025","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130399_bb0065","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1080\/15548627.2024.2431472","article-title":"Upregulation of ISG15 induced by MAPT\/tau accumulation represses autophagic flux by inhibiting HDAC6 activity: a vicious cycle in Alzheimer disease","volume":"21","author":"Liu","year":"2025","journal-title":"Autophagy"},{"key":"10.1016\/j.bmcl.2025.130399_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114920","article-title":"Histone deacetylases (HDACs) as the promising immunotherapeutic targets for hematologic cancer treatment","volume":"245","author":"Yang","year":"2023","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130399_bb0075","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.2147\/OTT.S194986","article-title":"Histone deacetylase 6 is overexpressed and promotes tumor growth of colon cancer through regulation of the MAPK\/ERK signal pathway","volume":"12","author":"Zhang","year":"2019","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.bmcl.2025.130399_bb0080","article-title":"HDAC6 and USP9X control glutamine metabolism by stabilizing GS to promote glioblastoma tumorigenesis","author":"Kim","year":"2025","journal-title":"Adv Sci (Weinheim, Baden-Wurttemberg, Germany)"},{"key":"10.1016\/j.bmcl.2025.130399_bb0085","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41586-024-08248-5","article-title":"Human HDAC6 senses valine abundancy to regulate DNA damage","volume":"637","author":"Jin","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.bmcl.2025.130399_bb0090","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10120-020-01108-x","article-title":"HDAC6\/HNF4\u03b1 loop mediated by miR-1 promotes bile acids-induced gastric intestinal metaplasia","volume":"24","author":"Wang","year":"2021","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.bmcl.2025.130399_bb0095","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1038\/onc.2013.241","article-title":"Oncogenic Shp2 disturbs microtubule regulation to cause HDAC6-dependent ERK hyperactivation","volume":"33","author":"Tien","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.bmcl.2025.130399_bb0100","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2010.96","article-title":"C6-ceramide synergistically potentiates the anti-tumor effects of histone deacetylase inhibitors via AKT dephosphorylation and alpha-tubulin hyperacetylation both in vitro and in vivo","volume":"2","author":"Zhu","year":"2011","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.bmcl.2025.130399_bb0105","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10420","article-title":"The Shp2-induced epithelial disorganization defect is reversed by HDAC6 inhibition independent of Cdc42","volume":"7","author":"Tien","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.bmcl.2025.130399_bb0110","article-title":"HDAC6 regulates epidermal growth factor receptor (EGFR) endocytic trafficking and degradation in renal epithelial cells","volume":"7","author":"Liu","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bmcl.2025.130399_bb0115","doi-asserted-by":"crossref","first-page":"9118","DOI":"10.18632\/oncotarget.7001","article-title":"MIIP accelerates epidermal growth factor receptor protein turnover and attenuates proliferation in non-small cell lung cancer","volume":"7","author":"Wen","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bmcl.2025.130399_bb0120","article-title":"Metabolic regulation of cytoskeleton functions by HDAC6-catalyzed \u03b1-tubulin lactylation","volume":"15(1):8377","author":"Sun","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.bmcl.2025.130399_bb0125","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.4161\/15384047.2014.956632","article-title":"HDAC6 regulates neuroblastoma cell migration and may play a role in the invasion process","volume":"15","author":"Zhang","year":"2014","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.bmcl.2025.130399_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.123219","article-title":"Curriculum vitae of HDAC6 in solid tumors","volume":"230","author":"Zheng","year":"2023","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.bmcl.2025.130399_bb0135","first-page":"35","article-title":"Clinical use and applications of histone deacetylase inhibitors in multiple myeloma","volume":"8","author":"Tandon","year":"2016","journal-title":"Clin Pharmacol: Adv Appl"},{"key":"10.1016\/j.bmcl.2025.130399_bb0140","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3892\/ol.2021.12462","article-title":"HDAC6-selective inhibitors enhance anticancer effects of paclitaxel in ovarian cancer cells","volume":"21","author":"Yoo","year":"2021","journal-title":"Oncol Lett"},{"key":"10.1016\/j.bmcl.2025.130399_bb0145","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.1158\/1078-0432.CCR-21-0238","article-title":"Preclinical development and first-in-human study of KA2507, a selective and potent inhibitor of histone deacetylase 6, for patients with refractory solid tumors","volume":"27","author":"Tsimberidou","year":"2021","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bmcl.2025.130399_bb0150","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70158","article-title":"Rational design, synthesis, and biological assessment of potential indole-capped HDAC6 inhibitors for gastric Cancer suppression","volume":"6","author":"Gao","year":"2025","journal-title":"MedComm"},{"key":"10.1016\/j.bmcl.2025.130399_bb0155","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1021\/acs.jmedchem.0c01782","article-title":"A review of progress in histone deacetylase 6 inhibitors research: structural specificity and functional diversity","volume":"64","author":"Zhang","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2025.130399_bb0160","doi-asserted-by":"crossref","first-page":"13459","DOI":"10.1073\/pnas.1718823114","article-title":"Unusual zinc-binding mode of HDAC6-selective hydroxamate inhibitors","volume":"114","author":"Porter","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bmcl.2025.130399_bb0165","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nchembio.2134","article-title":"Histone deacetylase 6 structure and molecular basis of catalysis and inhibition","volume":"12","author":"Hai","year":"2016","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.bmcl.2025.130399_bb0170","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/nchembio.2140","article-title":"Structural insights into HDAC6 tubulin deacetylation and its selective inhibition","volume":"12","author":"Miyake","year":"2016","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.bmcl.2025.130399_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.127023","article-title":"Structural determinants of affinity and selectivity in the binding of inhibitors to histone deacetylase 6","volume":"30","author":"Osko","year":"2020","journal-title":"Bioorg Med Chem Lett"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X25003087?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X25003087?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T16:17:16Z","timestamp":1785169036000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X25003087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":35,"alternative-id":["S0960894X25003087"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2025.130399","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and biological evaluation of novel histone deacetylase 6 inhibitors containing indole-based cap groups","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2025.130399","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"130399"}}